Does adjuvant vaccine therapy really have activity in malignant melanoma?

J Clin Oncol. 2007 Oct 10;25(29):4693; author reply 4693-5. doi: 10.1200/JCO.2007.13.3389.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cancer Vaccines / immunology
  • Cancer Vaccines / therapeutic use*
  • Clinical Trials as Topic
  • Combined Modality Therapy
  • Dose-Response Relationship, Drug
  • Drug Combinations
  • Humans
  • Immunotherapy, Active*
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Melanoma / secondary
  • Melanoma / therapy*
  • Neoplasm Recurrence, Local
  • Recombinant Proteins
  • Research Design
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*

Substances

  • Cancer Vaccines
  • Drug Combinations
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins